Hyperglycemia induced by acute central fluoxetine administration: role of the central CRH system and 5-HT3 receptors
- 30 June 2004
- journal article
- Published by Elsevier in Neuropeptides
- Vol. 38 (2-3) , 98-105
- https://doi.org/10.1016/j.npep.2004.04.004
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Central 5-HT3 Receptor Stimulation by m-CPBG Increases Blood Glucose in RatsHormone and Metabolic Research, 2002
- The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormoneInternational Journal of Obesity, 2001
- Selective serotonin reuptake inhibitors and neuroendocrine functionLife Sciences, 1999
- Role of serotonin in the amygdala in hypothalamo-pituitaryadrenocortical responsesNeuroReport, 1998
- Role of central neural mechanisms in the regulation of hepatic glucose metabolismLife Sciences, 1997
- Biogenic amines in the guinea pig endocrine pancreasLife Sciences, 1992
- β-Endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary actionBrain Research, 1990
- Intrahypothalamic microinfusion of corticotropin-releasing factor elevates blood glucose and free fatty acids in ratsJournal of the Autonomic Nervous System, 1988
- EFFECT OF THE ADMINISTRATION OF L‐5‐HYDROXYTRYPTOPHAN AND A MONOAMINE OXIDASE INHIBITOR ON GLUCOSE METABOLISM IN RAT BRAINJournal of Neurochemistry, 1978
- Effects of Serotonin, of its Biosynthetic Precursors and of the Anti-Serotonin Agent Metergoline on the Release of Glucagon and Insulin from Rat PancreasHormone and Metabolic Research, 1978